|
Index of reports
> Cases with Condition Aggravated ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Keppra (Levetiracetam) where reactions include condition aggravated. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Keppra side effects in 18 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08
Patient: 18 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Drug Interaction, Condition Aggravated, Convulsion
Drug(s) suspected as cause:
Lamotrigine
Dosage: 200 mg;bid;po
Administration route: Oral
Indication: Epilepsy
Start date: 2010-11-01
Keppra
Indication: Product Used FOR Unknown Indication
Nexplanon
Dosage: 68 mg;sbde
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-01
Other drugs received by patient: Doxycycline; Loratadine
Possible Keppra side effects in 18 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-07
Patient: 18 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Condition Aggravated, Drug Interaction, Convulsion
Drug(s) suspected as cause:
Nexplanon
Dosage: 68 mg, subdermal
Indication: Contraception
Start date: 2011-03-01
Lamotrigine
Dosage: 200 mg, 2 in 1 d, oral
Administration route: Oral
Indication: Epilepsy
Start date: 2010-11-01
Keppra
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Doxycycline; Loratadine
Possible Keppra side effects in 85 year old male
Reported by a pharmacist from United States on 2012-05-01
Patient: 85 year old male, weighing 77.2 kg (169.8 pounds)
Reactions: Acute Sinusitis, Dementia, Encephalopathy, Condition Aggravated
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Keppra
Dosage: 280mg x 3 day qhs po recent
Administration route: Oral
Indication: Convulsion
Prednisone
Dosage: recent
Indication: Pneumonia
Levaquin
Dosage: recent
Indication: Pneumonia
Other drugs received by patient: Simvastatin; Etodolac; Altace; Ultram; Donepezil HCL; Uloric; Risperdal; Namenda
Possible Keppra side effects in 18 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24
Patient: 18 year old female
Reactions: Condition Aggravated, Drug Interaction, Convulsion
Drug(s) suspected as cause:
Nexplanon
Dosage: 69 mg, subdemal
Indication: Contraception
Start date: 2011-03-01
Keppra
Indication: Product Used FOR Unknown Indication
Lamotrigine
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Loratadine
Possible Keppra side effects in 53 year old male
Reported by a physician from France on 2012-02-03
Patient: 53 year old male
Reactions: Anaemia, Condition Aggravated, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aranesp
Dosage: 50 mug, q2wk
Indication: Product Used FOR Unknown Indication
Prednisone TAB
Dosage: 30 mg/kg, qd
Administration route: Oral
Start date: 2011-05-01
Keppra
Eupressyl
Dosage: 90 mg, qd
Administration route: Oral
Start date: 2011-05-29
Kayexalate
Dosage: 15 g, 3 times/wk
Administration route: Oral
Start date: 2011-06-03
Citalopram Hydrobromide
Dosage: 20 unk, unk
Administration route: Oral
Calcium Carbonate
Dosage: unk
Administration route: Oral
Renagel
Dosage: unk unk, qd
Administration route: Oral
Possible Keppra side effects in female
Reported by a individual with unspecified qualification from United States on 2012-02-03
Patient: female, weighing 53.2 kg (117.0 pounds)
Reactions: Pain, Nocturia, Headache, Hot Flush, Unevaluable Event, Tearfulness, Product Quality Issue, Drug Effect Decreased, Condition Aggravated, Cognitive Disorder, Amnesia, Negativism, Apathy, Irritability, Affect Lability, Dependence, Sleep Disorder, Activities of Daily Living Impaired, Sinus Headache, Disturbance in Attention, Ear Pain
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Keppra
Dosage: 250mg keppra 2x/day oral, pill no other treatment since may 2009
Administration route: Oral
Indication: Brain Neoplasm Malignant
Start date: 2009-12-01
Keppra
Dosage: 250mg keppra 2x/day oral, pill no other treatment since may 2009
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-12-01
Keppra
Dosage: 250mg keppra 2x/day oral, pill no other treatment since may 2009
Administration route: Oral
Indication: Convulsion
Start date: 2009-12-01
Possible Keppra side effects in 24 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-30
Patient: 24 year old female
Reactions: Condition Aggravated
Drug(s) suspected as cause:
Topamax
Dosage: (175 mg, 75 mg in am+100mg at bedtime oral)
Administration route: Oral
Indication: Epilepsy
Start date: 2011-09-01
Suboxone
Dosage: (12 mg, daily dose: 12mg; cuts an 8mg strip to achieve dose sublingual)
Indication: Drug Dependence
Start date: 2011-07-01
Keppra
Dosage: (1000 mg, daily dose: 100mg oral)
Administration route: Oral
Indication: Epilepsy
Start date: 2011-09-01
Other drugs received by patient: Phenobarbital TAB
Possible Keppra side effects in 17 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: 17 year old female
Reactions: Multi-Organ Failure, Agranulocytosis, Histiocytosis Haematophagic, Condition Aggravated, Pancytopenia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Keppra
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-06
Sufenta Preservative Free
Dosage: unk
Indication: Sedation
Start date: 2008-11-29
End date: 2008-12-25
Urbanyl
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-15
Cyclophosphamide
Dosage: 750.0 mg, 1x/cyc
Indication: Sjogren's Syndrome
Start date: 2008-12-25
Phenobarbital TAB
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-01
Pentothal
Dosage: unk
Indication: Sedation
Start date: 2008-12-08
Vancomycin HCL
Dosage: unk
Indication: Pneumonia Staphylococcal
Start date: 2008-12-01
Piperacillin and Tazobactam
Dosage: unk
Indication: Escherichia Bacteraemia
Start date: 2008-12-25
Pantoprazole Sodium
Dosage: unk
Indication: Prophylaxis Against Gastrointestinal Ulcer
Start date: 2008-12-01
Diprivan
Dosage: unk
Indication: Sedation
Start date: 2008-12-18
Depakene
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-26
Amikacin
Dosage: unk
Indication: Escherichia Bacteraemia
Start date: 2008-12-25
Fosphenytoin Sodium
Dosage: unk
Indication: Status Epilepticus
Start date: 2008-12-09
End date: 2008-12-01
Other drugs received by patient: Paracetamol; Neostigmine; Duphalac; Solu-Medrol; Norepinephrine; Neupogen
Possible Keppra side effects in 53 year old male
Reported by a physician from France on 2011-12-29
Patient: 53 year old male
Reactions: Anaemia, Condition Aggravated, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Citalopram Basics
Dosage: 20 unk, unk
Administration route: Oral
Prednisone TAB
Dosage: 30 mg/kg, qd
Administration route: Oral
Start date: 2011-05-01
Keppra
Renagel
Dosage: unk unk, qd
Administration route: Oral
Kayexalate
Dosage: 15 g, 3 times/wk
Administration route: Oral
Start date: 2011-06-03
Eupressyl / 00631801 /
Dosage: 90 mg, qd
Administration route: Oral
Start date: 2011-05-29
Aranesp
Dosage: 50 mug, q2wk
Indication: Product Used FOR Unknown Indication
Calcium Carbonate
Dosage: unk
Administration route: Oral
Possible Keppra side effects in 83 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-25
Patient: 83 year old female
Reactions: Condition Aggravated, Cholestasis, Hepatic Cirrhosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Calciparine
Dosage: 2 in 1 d, subcutaneous
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-27
End date: 2011-07-04
Keppra
Dosage: 500 mg milligram(s), 2 in 1 d, intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-30
End date: 2011-07-12
Novolog
Dosage: 1 in 1 d, subcutaneous
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-01
End date: 2011-07-04
Onfi
Dosage: 10 mg milligram(s), 1 in 1 d, oral
Administration route: Oral
Indication: Status Epilepticus
Start date: 2011-06-27
Insulin
Dosage: 1 in 1 d, subcutaneous
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-30
End date: 2011-07-04
Acetaminophen
Dosage: 1 g gram(s), 3 in 1 d, oral
Administration route: Oral
Indication: Pain
Start date: 2011-07-02
End date: 2011-07-12
Other drugs received by patient: Propranolol; Oxazepam; Lormetazepam; Mianserine (Mianserin Hydrochloride); Aldactone; Pantoprazole; Diffu K (Potassium Chloride0; Furosemide
Possible Keppra side effects in 3 year old female
Reported by a consumer/non-health professional from United States on 2011-11-15
Patient: 3 year old female, weighing 13.2 kg (29.0 pounds)
Reactions: Alopecia, Condition Aggravated, Convulsion
Drug(s) suspected as cause:
Increlex
Dosage: 30 units (15 units, 2 in 1 d), subcutaneous
Indication: Growth Hormone Deficiency
Start date: 2011-03-01
Dilantin
Dosage: 4 ml (2 ml, 2 in 1 d), other
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-01
Keppra
Dosage: 6 ml (3 ml, 2 in 1 d), other
Indication: Convulsion
Start date: 2011-04-01
Other drugs received by patient: Ranitidine Hydrochloride; Phenobarbital TAB; Multivitamin (Multivitamin); Tobramycin; Robinul (Glycopyrronium Bromide); Albuterol; Qvar MDI (Beclometasone Dipropionate); Ipratropium Bromide; Calcitriol
Possible Keppra side effects in 3 year old female
Reported by a consumer/non-health professional from United States on 2011-11-03
Patient: 3 year old female, weighing 13.2 kg (29.0 pounds)
Reactions: Alopecia, Condition Aggravated, Convulsion
Drug(s) suspected as cause:
Increlex
Dosage: 30 units (15 units, 2 in 1 d), subcutaneous
Indication: Growth Hormone Deficiency
Start date: 2011-03-01
Keppra
Dosage: 6 ml (3 ml, 2 in 1 d), other
Indication: Convulsion
Start date: 2011-04-01
Dilantin
Dosage: 4 ml (2 ml, 2 in 1 d), other
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-01
Other drugs received by patient: Phenobarbital TAB; Robinul (Glycopyrronium Bromide); Ipratropium Bromide; Ranititine (Ranitidine); Tobramycin; Qvar MD (Beclometasone Dipropionate); Calcitriol; Multi-Vitamin; Albuterol
Possible Keppra side effects in 3 year old female
Reported by a consumer/non-health professional from United States on 2011-10-18
Patient: 3 year old female, weighing 13.2 kg (29.0 pounds)
Reactions: Alopecia, Condition Aggravated, Convulsion
Drug(s) suspected as cause:
Dilantin
Dosage: 4 ml (2 ml, 2 in 1 d), other
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-01
Increlex
Dosage: 30 units (15 units, 2 in 1 d), subcutaneous
Indication: Growth Hormone Deficiency
Start date: 2011-03-01
Keppra
Dosage: 6 ml (3 ml, 2 in 1 d), other
Indication: Convulsion
Start date: 2011-04-01
Other drugs received by patient: Qvar MDI (Beclometasone Dipropionate); Ranitdine (Ranitdine); Tobramycin; Phenobarbital TAB; Albuterol (Salbuterol); Robinul (Glycopyyrronium Bromide); Calcitriol; Ipratropium Bromide; Multivitamin (Multivitamin / 00831701 / )
Possible Keppra side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2011-10-12
Patient: 24 year old female
Reactions: Wrong Technique in Drug Usage Process, Condition Aggravated, Convulsion
Drug(s) suspected as cause:
Keppra
Administration route: Oral
Indication: Epilepsy
Start date: 2011-09-01
Suboxone
Indication: Drug Dependence
Start date: 2011-07-01
Topamax
Dosage: takes 75 mg in am and 100 mg at bedtime
Administration route: Oral
Indication: Epilepsy
Start date: 2011-09-01
Other drugs received by patient: Phenobarbital TAB
|
